Assessing Pain by the painDETECT Questionnaire (PDQ)

计划入组 7,056 人 · 首次发布于 2024 年 5 月 7 日

Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis.

计划入组 80 人 · 首次发布于 2019 年 6 月 28 日

The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs

计划入组 108 人 · 首次发布于 2021 年 8 月 12 日

DMARDs

Edwards Syndrome (Trisomy 18) therapeutics(Elixirgen therapeutics)

EDWARDS PHARMACEUTICALS, INC.

United States

Edwards Lifesciences LLC

United States

EDWARDS LIFESCIENCES JAPAN LLC

Japan

Large Real-World Study Finds No Increased Cancer or Cardiovascular Risk with JAK Inhibitors in Rheumatoid Arthritis

Systematic Review Reveals Significant Disparities in US Biologics Access Across Immunology Specialties

Secukinumab and Adalimumab Show Distinct Benefits in Psoriatic Arthritis Treatment